Search results
Banner Health program provides cancer patients ‘home away from home’ in Gilbert
KTVK 3TV Phoenix· 6 days agoGoing through cancer is difficult enough. Cecilia Cortes was diagnosed with acute lymphoblastic ...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks· 6 days agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective response rate of almost 52% in certain heavily pre-treated patients with ovarian cancer.
Why C.J. Stroud believes John Metchie III is poised for a breakout season in 2024
Roll Tide Wire via Yahoo Sports· 4 days agoThough he had suffered a torn ACL in the SEC championship game just a few months prior to being...
HUTCHMED Initiates Phase I Trial of Menin Inhibitor HMPL-506 in Patients with Hematological...
Benzinga· 7 days agoHONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated Phase I clinical trial of its menin
Dr. Jeff Hersh addresses cause, effects and complications of Graft vs Host Disease
The Metrowest Daily News via Yahoo News· 5 days agoGraft vs Host Disease occurs when white blood cells produced by donated stem cells identify the...
Is Geron Stock a Buy Following Its First New Drug Approval?
Motley Fool via Yahoo Finance· 5 days agoRytelo is a new treatment for an underserved population. That's generally a recipe for success in...
Kadence's Triumph: An Inspiring Indiana story of strength and community support
WTHR Indianapolis· 7 days agoAfter two years of battling aggressive cancer, 10-year-old Kadence Turientine is now cancer-free. "I...
2024 Warren Alpert Foundation Prize Honors Four Pi | Newswise
Newswise· 2 days agoThe 2024 Warren Alpert Foundation Prize has been awarded to four scientists whose transformational discoveries led to the creation of chimeric antigen receptor (CAR) T cells, a treatment ...
StockNews.com Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)
ETF DAILY NEWS· 9 hours agoInvestment analysts at StockNews.com began coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Free Report) in a note issued to investors on Thursday. The brokerage set a “sell” rating ...
Age is just a number: Immune cell ‘epigenetic cl | Newswise
Newswise· 1 day agoScientists at St. Jude Children’s Research Hospital and the University of Minnesota investigated the...